NDATOPICALGEL
Approved
Jul 2015
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
4/8 — Partial
EPIDUO FORTE (adapalene and benzoyl peroxide) by Galderma is protein. First approved in 2015.
Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
EPIDUO FORTE is a fixed-dose topical gel combining adapalene (a retinoid modulator) and benzoyl peroxide (an oxidizing bactericidal agent) for the treatment of acne vulgaris. Adapalene modulates cellular differentiation and keratinization while benzoyl peroxide provides antimicrobial and keratolytic effects. This combination addresses multiple acne pathways in a single formulation.
$0.077BPart D
PeakAt peak lifecycle stage with modest Part D penetration, the brand maintains stable revenue but faces increasing competitive pressure requiring strategic portfolio defense and market share protection.
Mechanism of Action
protein. Biochemical and pharmacological profile studies have demonstrated that adapalene is a modulator of cellular differentiation, keratinization and inflammatory processes. However, the significance of these findings with regard to the mechanism of action of adapalene for the treatment of acne…
Pharmacologic Class:
Retinoid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
EPIDUO FORTE careers center on commercial execution and defensive market positioning within a mature, competitive acne franchise managed by Galderma's dermatology business unit. Roles emphasize sales effectiveness, payer negotiation, and maintaining market share against generic and newer competitors rather than launch innovation.
Brand Manager
Worked on EPIDUO FORTE at Galderma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.